<html><head><link rel="stylesheet" href="https://unpkg.com/mvp.css"></head><title>CCI approves the acquisition of less than 5% shareholding in Intas Pharmaceuticals Limited by Canary Investments Limited and Link Investment Trust II</title><body><h1>CCI approves the acquisition of less than 5% shareholding in Intas Pharmaceuticals Limited by Canary Investments Limited and Link Investment Trust II</h1><p style="text-align:justify"><span style="font-size:16px"><span style='font-family:"Times New Roman","serif"'>The Competition Commission of India (CCI) approves the acquisition of less than 5% shareholding in Intas Pharmaceuticals Limited by Canary Investments Limited and Link Investment Trust II, under Section 31(1) of the Competition Act, 2002.</span></span></p>
<p style="text-align:justify"><span style="font-size:16px"><span style='font-family:"Times New Roman","serif"'>The Proposed Combination relates to acquisition of less than 5% shareholding ofIntas Pharmaceuticals Limited (<strong>Intas</strong>) by Canary Investments Limited (<strong>Canary</strong>) and Link Investment Trust II (<strong>Link II</strong>).</span></span></p>
<p style="text-align:justify"><span style="font-size:16px"><span style='font-family:"Times New Roman","serif"'>Canary is an investment company registered in Mauritius. Link II is a private trust created and registered under the laws of India.Intas is a public limited company incorporated and registered under the laws of India. Intas is said to be a vertically integrated global pharmaceutical formulation development, manufacturing, and marketing company.</span></span></p>
<p style="text-align:justify"><span style="font-size:16px"><span style='font-family:"Times New Roman","serif"'>The Commission approved the Proposed Combination subject to the carrying out of modifications proposed by Canary and Link II.</span></span></p>
<p style="text-align:justify"><span style="font-size:16px"><span style="background-color:#f5f8fa"><span style='font-family:"Times New Roman","serif"'>The detailed order of the CCI will follow.</span></span></span></p>
<p style="text-align:justify">Â </p>
</body></html>